Mouse salivary glands and human β-defensin-2 as a study model for antimicrobial gene therapy: technical considerations
- 31 October 2006
- journal article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 28 (4) , 352-360
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Defensins in innate antiviral immunityNature Reviews Immunology, 2006
- Human β-Defensins Suppress Human Immunodeficiency Virus Infection: Potential Role in Mucosal ProtectionJournal of Virology, 2005
- A cutaneous gene therapy approach to treat infection through keratinocyte‐targeted overexpression of antimicrobial peptidesThe FASEB Journal, 2004
- Multiple Roles of Antimicrobial Defensins, Cathelicidins, and Eosinophil-Derived Neurotoxin in Host DefenseAnnual Review of Immunology, 2004
- Human β-Defensins 2 and 3 Demonstrate Strain-Selective Activity against Oral MicroorganismsJournal of Clinical Microbiology, 2004
- Human β‐defensin‐2 functions as a chemotactic agent for tumour necrosis factor‐α‐treated human neutrophilsImmunology, 2004
- A Model for Antimicrobial Gene Therapy: Demonstration of Human β -Defensin 2 Antimicrobial Activities In VivoHuman Gene Therapy, 2002
- Discovery of new human β-defensins using a genomics-based approachGene, 2001
- Human beta-defensin-2The International Journal of Biochemistry & Cell Biology, 1999
- Transfer of a cathelicidin peptide antibiotic gene restores bacterial killing in a cystic fibrosis xenograft modelJournal of Clinical Investigation, 1999